Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 25, Pages 3588-3598
Publisher
Springer Nature
Online
2017-02-07
DOI
10.1038/onc.2016.510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma
- (2017) Shoji Hanada et al. Cancer Biomarkers
- Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway
- (2016) Brian P. Ziemba et al. BIOPHYSICAL JOURNAL
- Secretome protein signature of human pancreatic cancer stem-like cells
- (2016) Jessica Brandi et al. Journal of Proteomics
- Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
- (2015) H. I. Wettersten et al. CANCER RESEARCH
- Emerging therapeutic approaches in renal cell carcinoma
- (2015) Hiral Parekh et al. Expert Review of Anticancer Therapy
- Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma
- (2015) Wael Naboulsi et al. JOURNAL OF PROTEOME RESEARCH
- Understanding multicellular function and disease with human tissue-specific networks
- (2015) Casey S Greene et al. NATURE GENETICS
- Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
- (2015) L Zhou et al. ONCOGENE
- The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization
- (2015) Timothy D. Rohrbach et al. PLoS One
- Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment
- (2015) Ching-Hsien Chen et al. Oncotarget
- Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma
- (2015) Kyung Seok Han et al. NEOPLASIA
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- A Novel Predictor of Cancer Malignancy: Up-regulation of Myristoylated Alanine-Rich C Kinase Substrate Phosphorylation in Lung Cancer
- (2014) Ching-Hsien Chen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Targeting Myristoylated Alanine-Rich C Kinase Substrate Phosphorylation Site Domain in Lung Cancer. Mechanisms and Therapeutic Implications
- (2014) Ching-Hsien Chen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4
- (2014) Christina A. von Roemeling et al. CANCER RESEARCH
- Molecular Biomarkers in Advanced Renal Cell Carcinoma
- (2014) P. Maroto et al. CLINICAL CANCER RESEARCH
- Renal cell carcinoma
- (2014) Daniel Su et al. CURRENT OPINION IN ONCOLOGY
- The role of HIF1α in renal cell carcinoma tumorigenesis
- (2014) Lorraine J. Gudas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma
- (2014) Y Yang et al. LEUKEMIA
- Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival
- (2014) M Bickeböller et al. ONCOGENE
- Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy
- (2014) Danielle Ferraro et al. Therapeutic Advances in Medical Oncology
- Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo
- (2013) Krista Rombouts et al. CANCER LETTERS
- The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma
- (2013) T. K. Choueiri et al. CLINICAL CANCER RESEARCH
- Emerging antiangiogenics for renal cancer
- (2013) Charlotte Domblides et al. EXPERT OPINION ON EMERGING DRUGS
- Targeting angiogenesis in renal cell carcinoma
- (2013) Edwin M Posadas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
- (2013) Brigid C. Browne et al. FEBS Journal
- A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis
- (2013) C-H Chen et al. ONCOGENE
- Regorafenib (BAY 73–4506): Stromal and Oncogenic Multikinase Inhibitor with Potential Activity in Renal Cell Carcinoma
- (2013) Kamarul Zaki et al. Current Oncology Reports
- Novel tyrosine kinase inhibitors for renal cell carcinoma
- (2013) Tanya B Dorff et al. Expert Review of Clinical Pharmacology
- MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma
- (2012) J. S. Jarboe et al. CLINICAL CANCER RESEARCH
- Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
- (2012) Tim Eisen et al. LANCET ONCOLOGY
- The Hypoxia-Associated Factor Switches Cells from HIF-1 - to HIF-2 -Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
- (2011) M. Y. Koh et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year
- (2011) Marine Gross-Goupil et al. Current Urology Reports
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- PhosphoMARCKS drives motility of mouse melanoma cells
- (2010) Xiangyu Chen et al. CELLULAR SIGNALLING
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- The MARCKS Protein Plays a Critical Role in Phosphatidylinositol 4,5-Bisphosphate Metabolism and Directed Cell Movement in Vascular Endothelial Cells
- (2010) Hermann Kalwa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidermal Growth Factor Receptor Variant III-Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression
- (2009) J. Micallef et al. CANCER RESEARCH
- VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy
- (2009) C. Lance Cowey et al. Current Oncology Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation